Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Report Guidance | 5 | 1 |
| Clinical Trials by Region | 6 | 8 |
| Clinical Trials and Average Enrollment by Country | 7 | 3 |
| Top Countries Contributing to Clinical Trials in Asia-Pacific | 10 | 1 |
| Top Five Countries Contributing to Clinical Trials in Europe | 11 | 1 |
| Top Countries Contributing to Clinical Trials in North America | 12 | 1 |
| Top Five Countries Contributing to Clinical Trials in Middle East and Africa | 13 | 1 |
| Clinical Trials by G7 Countries: Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials | 14 | 2 |
| Clinical Trials by Phase in G7 Countries | 16 | 1 |
| Clinical Trials in G7 Countries by Trial Status | 17 | 1 |
| Clinical Trials by E7 Countries: Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials | 18 | 2 |
| Clinical Trials in E7 Countries by Trial Status | 20 | 1 |
| Clinical Trials by Phase | 21 | 2 |
| In Progress Trials by Phase | 22 | 1 |
| Clinical Trials by Trial Status | 23 | 1 |
| Clinical Trials by End Point Status | 24 | 1 |
| Subjects Recruited Over a Period of Time | 25 | 1 |
| Clinical Trials by Sponsor Type | 26 | 1 |
| Prominent Sponsors | 27 | 3 |
| Top Companies Participating in Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials | 28 | 2 |
| Prominent Drugs | 30 | 1 |
| Latest Clinical Trials News on Ebolavirus Infections (Ebola Hemorrhagic Fever) | 31 | 5 |
| Oct 04, 2016: RespireRx Pharmaceuticals Retracts Efficacy Data in September 12, 2016 Press Release Announcing Preliminary Top-Line Analysis of Safety and Efficacy Data from Duke University Phase 2A Clinical Trial of CX 1739 | 31 | 1 |
| Sep 07, 2016: BioCryst Announces Positive Study Results for BCX4430 Delayed Treatment of Ebola Virus Infection in a Non-Human Primate Model | 31 | 1 |
| Aug 24, 2016: Experts at World Congress of Internal Medicines Reinforce Importance of BETADINE in Disease Prevention, Infection Control and Oral Mucositis Treatment | 31 | 1 |
| Aug 11, 2016: Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen | 32 | 1 |
| Jul 28, 2016: Ranpirnase Shows Antiviral Effect Against Ebola | 33 | 1 |
| Jul 18, 2016: Soligenix Announces Presentation of Positive Preliminary Results of a Heat Stable Ebola Vaccine Formulation | 33 | 2 |
| Jul 14, 2016: Yisheng Biopharma and the United States Army Medical Research Institute of Infectious Diseases Announce Positive Animal Results of Vaccine Against Ebola Virus | 35 | 1 |
| Clinical Trial Profile Snapshots | 36 | 52 |
| Appendix | 88 | 3 |
| Abbreviations | 88 | 1 |
| Definitions | 88 | 1 |
| Research Methodology | 89 | 1 |
| Secondary Research | 89 | 1 |
| About GlobalData | 90 | 1 |
| Contact Us | 90 | 1 |
| Disclaimer | 90 | 1 |
| Source | 91 | 1 |
